Dr. Matthew Elmes is the Director of New Product Development at CannaCraft, one of the largest cannabis product manufacturers in the United States. Dr. Elmes holds a Ph.D. in Molecular and Cellular Biology from Stony Brook University in New York, where he focused on endocannabinoid and phytocannabinoid cellular transport mechanisms for his dissertation work. By the end of his graduate education he had authored over a dozen peer-reviewed scientific journal articles about cannabinoids and was named a co-inventor on a granted patent application. In 2018 Dr. Elmes began his postdoctoral work with Artelo Biosciences developing a novel class of endocannabinoid transport inhibitors. The compounds that he and his team developed are able to modulate endocannabinoid system signaling and hold great promise as non-addictive, anti-inflammatory and pain-killing drugs. Dr. Elmes recently transitioned to an industry position with CannaCraft, where he focuses on cannabis extraction methods, cannabinoid formulations and new product development for the CannaCraft brands Satori, Care By Design, and Absolute Xtracts.